dataesr/scientific-paragraphs-categorization huggingface dataset:
Acknowledgements The authors in this manuscript were working on behalf of BCAC, CCFR, CIMBA, CORECT, GECCO, OCAC, PRACTICAL,  CRUK ,  BPC3 ,  CAPS , PEGASUS, TRICL-ILCCO, ABCTB, APCB, BCFR, CONSIT TEAM, EMBRACE, GC-HBOC, GEMO, HEBON, kConFab/AOCS  Mod SQuaD , and  SWE-BRCA. The breast cancer genome-wide association analyses: BCAC is funded by  Cancer Research UK  [ C1287/A16563 ,  C1287/ A10118 ], the  European Union 's  Horizon 2020 Research and Innovation Programme  (grant numbers  634935  and  633784  for BRIDGES and B-CAST, respectively), and by the  European Community 's  Seventh Framework Programme  under grant agreement number  223175  (grant number  HEALTH-F2-2009-223175 ) (COGS). The  EU Horizon 2020 Research and Innovation Programme  funding source had no role in study design, data collection, data analysis, data interpretation, or writing of the report.
Genotyping of the OncoArray was funded by the  NIH  Grant  U19 CA148065 , and  Cancer UK  Grant  C1287/ A16563  and the  PERSPECTIVE  project supported by the  Government of Canada through Genome Canada  and the  Canadian Institutes of Health Research  (grant  GPH-129344 ) and, the  Ministère de l'Économie, Science et Innovation du Québec through Genome Québec  and the  PSR-SIIRI-701 grant , and the  Quebec Breast Cancer Foundation. Funding for the iCOGS infrastructure came from: the  European Community 's Seventh Framework No. 1121258  and the  NCRN. The coordination of EPIC is financially supported by the  European Commission (DG-SANCO)  and the  International Agency for Research on Cancer. The national cohorts are supported by:  Ligue Contre le Cancer ,  Institut Gustave Roussy, Mutuelle Générale de l'Education Nationale ,  Institut National de la Santé et de la Recherche Médicale (INSERM) (France) ;  German Cancer Aid ,  German Cancer Research Center (DKFZ) ,  Federal Ministry of Education and Research (BMBF) (Germany) ; the  Hellenic Health Foundation , the  Stavros Niarchos Foundation (Greece) ;  Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy and National Research Council (Italy) ;  Dutch Ministry of Public Health, Welfare and Sports (VWS) ,  Netherlands Cancer Registry (NKR) ,  LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland) ,  World Cancer Research Fund (WCRF) ,  Statistics Netherlands  (The Netherlands);  Health Research Fund (FIS) ,  PI13/00061  to Granada,  PI13/01162  to  EPIC-Murcia, Regional Governments of Andalucía, Asturias, Basque Country, Murcia and Navarra, ISCIII RETIC  ( RD06/0020 ) (Spain);  Cancer Research UK  ( 14136  to  EPIC-Norfolk ;  C570/A16491  and  C8221/A19170  to  EPIC-Oxford ),  Medical Research Council  ( 1000143  to  EPIC-Norfolk ,  MR/M012190/1  to  EPIC-Oxford) (United Kingdom ).
The ESTHER study was supported by a grant from the  Baden Württemberg Ministry of Science, Research and Arts. Additional cases were recruited in the context of the VERDI study, which was supported by a grant from the  German Cancer Aid (Deutsche Krebshilfe ). FHRISK is funded from  NIHR  grant  PGfAR   0707-10031. The  GC-HBOC (German Consortium of Hereditary Breast  and  Ovarian Cancer ) is supported by the  German Cancer Aid  (grant no  110837 , coordinator:  Rita K. Schmutzler , Cologne). This work was also funded by the  European Regional Development Fund and Free State of Saxony, Germany (LIFE -Leipzig Research Centre for Civilization Diseases , project numbers  713-241202 ,  713-241202 ,  14505/2470 , and  14575/2470 ). The GENICA was funded by the  Federal Ministry of Education and Research (BMBF)   Germany grants   01KW9975/5 ,  01KW9976/8 ,  01KW9977/0 , and  01KW0114 , the  Robert Bosch Foundation, Stuttgart, Deutsches Krebsforschungszentrum (DKFZ) ,  Heidelberg , the  Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA) ,  Bochum , as well as the  Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany.
The GEPARSIXTO study was conducted by the  German Breast Group GmbH. The GESBC was supported by the  Deutsche Krebshilfe  e. V. [70492] and the  German Cancer Research Center (DKFZ). GLACIER was supported by  Breast Cancer Now, CRUK and Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London. The HABCS study was supported by the  Claudia von Schilling Foundation for Breast Cancer Research , by the  Lower Saxonian Cancer Society , and by the  Rudolf-Bartling Foundation. The HEBCS was financially supported by the  Helsinki University Central Hospital Research Fund ,  Academy of Finland  ( 266528 ), the  Finnish Cancer Society , and the  Sigrid Juselius Foundation. The HERPACC was supported by  MEXT Kakenhi  (No. 170150181  and  26253041 ) from the  Ministry of Education, Science, Sports, Culture and Technology of Japan , by a  Grant-in-Aid for the Third Term Comprehensive 10-Year Strategy for Cancer Control  from  Ministry Health, Labour and Welfare of Japan , by  Health and Labour Sciences Research Grants for Research on Applying Health Technology from Ministry Health, Labour and Welfare of Japan , by  National Cancer Center Research and Development Fund, and "Practical Research for Innovative Cancer Control  ( 15ck0106177h0001 )" from  Japan Agency for Medical Research and development, AMED , and  Cancer Bio Bank Aichi.
The HMBCS was supported by a grant from the  Friends of Hannover Medical School  and by the  Rudolf Bartling Foundation. The HUBCS was supported by a grant from the  German Federal Ministry of Research and Education  ( RUS08/017 ), and by the  Russian Foundation for Basic Research  and the  Federal Agency for Scientific Organizations  for support the Bioresource collections and RFBR grants  14-04-97088 ,  17-29-06014 , and  17-44-020498. ICICLE was supported by  Breast Cancer Now, CRUK, and Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London. Financial support for KARBAC was provided through the regional agreement on medical training and clinical research (A. L. F. ) between  Stockholm County Council and Karolinska Institutet , the  Swedish Cancer Society , The Gustav V Jubilee foundation and Bert von Kantzows foundation.
The KARMA study was supported by  Märit and Hans Rausings Initiative Against Breast Cancer. The KBCP was financially supported by the special Government Funding (E. V. O. ) of  Kuopio University Hospital  grants,  Cancer Fund of North Savo , the  Finnish Cancer Organizations , and by the strategic funding of the  University of Eastern Finland. kConFab is supported by a grant from the  National Breast Cancer Foundation , and previously by the  National Health and Medical Research Council (NHMRC) , the  Queensland Cancer Fund , the  Cancer Councils of New South Wales, Victoria , Tasmania and  South Australia , and the  Cancer Foundation of Western Australia. Financial support for the AOCS was provided by the  United States Army Medical Research and Materiel Command  [ DAMD17-01-1-0729 ],  Cancer Council Victoria, Queensland Cancer Fund, Cancer Council New South Wales, Cancer Council South Australia , The  Cancer Foundation of Western Australia, Cancer Council Tasmania  and the  National Health and Medical Research Council of Australia  (NHMRC; 400413, 400281, 199600).
The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the CDC or the  Mississippi Cancer Registry. SEARCH is funded by  Cancer Research UK  [ C490/A10124 ,  C490/ A16561 ] and supported by the  UK National Institute for Health Research Biomedical Research Centre  at the  University of Cambridge. The  University of Cambridge  has received salary support for PDPP from the  NHS in the East of England through the Clinical Academic Reserve. SEBCS was supported by the  BRL (Basic Research Laboratory ) program through the  National Research Foundation of Korea  funded by the  Ministry of Education, Science and Technology  ( 2012-0000347 ). SGBCC is funded by the  NUS startup Grant, National University Cancer Institute Singapore (NCIS)   Centre Grant  and the  NMRC Clinician Scientist Award.
Additional controls were recruited by the  Singapore Consortium of Cohort Studies-Multi-ethnic cohort (SCCS-MEC ), which was funded by the  Biomedical Research Council , grant number:  05/1/21/19/425. The Sister Study (SIS-TER) is supported by the  Intramural Research Program  of the  NIH, National Institute of Environmental Health Sciences  ( Z01-ES044005  and  Z01-ES049033 ). The  Two Sister Study  ( 2SISTER ) was supported by the  Intramural Research Program  of the  NIH, National Institute of Environmental Health Sciences  ( Z01-ES044005  and  Z01-ES102245 ), and, also by a grant from  Susan G. Komen for the Cure , grant  FAS0703856. SKKDKFZS is supported by the  DKFZ. The SMC is funded by the  Swedish Cancer Foundation. The SZBCS was supported by Grant  PBZ_KBN_122/P05/2004. The TBCS was funded by The  National Cancer Institute, Thailand.
The TNBCC was supported by a  Specialized Program of Research Excellence (SPORE) in Breast Cancer  ( CA116201 ), a grant from the  Breast Cancer Research Foundation , a generous gift from the  David F. and Margaret T. Grohne Family Foundation. The TWBCS is supported by the  Taiwan Biobank  project of the  Institute of Biomedical Sciences, Academia Sinica, Taiwan. The UCIBCS component of this research was supported by the  NIH  [ CA58860 ,  CA92044 ] and the  Lon V Smith Foundation  [LVS39420]. The UKBGS is funded by  Breast Cancer Now  and the  Institute of Cancer Research (ICR), London. ICR  acknowledges  NHS  funding to the  NIHR Biomedical Research Centre. The UKOPS study was funded by  The Eve Appeal (The Oak Foundation ) and supported by the  National Institute for Health Research University College London Hospitals Biomedical Research Centre.
The US3SS study was supported by Massachusetts (K. M. E. ,  R01CA47305 ),  Wisconsin  (P. A. N. ,  R01 CA47147 ) and  New Hampshire  (L. T. -E. , R01CA69664) centers, and  Intramural Research Funds of the National Cancer Institute, Department of Health and Human Services, USA. The  USRT Study  was funded by  Intramural Research Funds of the National Cancer Institute, Department of Health and Human Services, USA. The WAABCS study was supported by grants from the  National Cancer Institute of the National Institutes of Health  ( R01 CA89085  and  P50 CA125183  and the  D43 TW009112  grant),  Susan G. Komen  ( SAC110026 ), the  Dr. Ralph and Marian Falk Medical Research Trust , and the  Avon Foundation for Women. The  WHI program  is funded by the  National Heart, Lung, and Blood Institute , the  US National Institutes of Health  and the  US Department of Health and Human Services  ( HHSN268201100046C ,  HHSN268201100001C ,  HHSN268201100002C ,  HHSN268201100003C ,  HHSN268201100004C , and  HHSN271201100004C ).
This work was also funded by  NCI   U19 CA148065-01. D. G. E. is supported by the all Manchester  NIHR Biomedical research center Manchester  ( IS-BRC-1215-20007 ). HUNBOCS,  Hungarian Breast  and  Ovarian Cancer Study  was supported by  Hungarian Research Grant   KTIA-OTKA CK-80745 ,  NKFI_OTKA K-112228. C. I. received support from the  Nontherapeutic Subject Registry Shared Resource at Georgetown University  ( NIH/NCI P30-CA-51008 ) and the  Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research. K. M. is supported by  CRUK   C18281/ A19169. City of Hope Clinical Cancer Community Research Network  and the  Hereditary Cancer Research Registry , supported in part by Award Number  RC4CA153828  (PI:  J Weitzel ) from the  National Cancer Institute  and the office of the Directory,  National Institutes of Health.
N01-PC-67001  and  N01-PC-35137 , and Contract No. HHSN26120100037C , and the  California Department of Public Health  (contracts  HHSN261201000035C  awarded to the  University of Southern California , and the following state cancer registries: A. Z. , C. O. , M. N. , N. C. , N. H. , and by the  Victoria Cancer Registry and Ontario Cancer Registry. ESTHER/VERDI was supported by grants from the  Baden-Württemberg Ministry of Science, Research and Arts  and the  German Cancer Aid. MCCS cohort recruitment was funded by  VicHealth  and  Cancer Council Victoria. GALEON:  FIS Intrasalud  ( PI13/01136 ). The MCCS was further supported by Australian  NHMRC  grants  509348 ,  209057 ,  251553 , and  504711  and by infrastructure provided by  Cancer Council Victoria. Cases and their vital status were ascertained through the  Victorian Cancer Registry (VCR)  and the  Australian Institute of Health and Welfare (AIHW) , including the  National Death Index  and the Australian Cancer Database.
MSKCC: the work at Sloan Kettering in New York was supported by the  Robert and Kate Niehaus Center for Inherited Cancer Genomics  and the  Romeo Milio Foundation. Moffitt: This work was supported by funding from the  National Institutes of Health  (grant numbers  R01 CA189184 ,  P30 CA076292 ),  Florida Department of Health Bankhead-Coley  Grant  09BN-13 , and the  University of South Florida Oehler Foundation. Moffitt contributions were supported in part by the  Total Cancer Care Initiative , Collaborative Data Services Core, and  Tissue Core at the H. Lee Moffitt Cancer Center & Research Institute , a  National Cancer Institute-designated Comprehensive Cancer Center  (grant number  P30 CA076292 ). SEARCH:  Cancer Research UK  ( C490/A16561 ). The Spanish study was supported by  Instituto de Salud Carlos III , co-funded by  FEDER  funds -a way to build Europe-(grants  PI14-613  and  PI09-1286 ),  Catalan Government DURSI  (grant  2014SGR647 ), and  Junta de Castilla y León  (grant  LE22A10-2 ).
Additionally, a subset of control samples was genotyped as part of the  Cancer Genetic Markers of Susceptibility (CGEMS) Prostate Cancer GWAS, Colon CGEMS pancreatic cancer scan (PanScan) , and the  Lung Cancer and Smoking study. The prostate and PanScan study datasets were accessed with appropriate approval through the dbGaP online resource (http://cgems. cancer. gov/data/)accession numbers phs000207. v1. p1 and phs000206. v3. p2, respectively, and the lung datasets were accessed from the dbGaP website (http://www. ncbi. nlm. nih. gov/gap)through accession number phs000093. v2. p2. Funding for the Lung Cancer and Smoking study was provided by  National Institutes of Health (NIH) ,  Genes, Environment and Health Initiative (GEI)   Z01 CP 010200 ,  NIH   U01 HG004446 , and  NIH   GEI U01 HG 004438.
The  University of Cambridge  has received salary support for PDPP from the  NHS in the East of England through the Clinical Academia Reserve. The prostate cancer genome-wide association analyses: we pay tribute to  Brian Henderson , who was a driving force behind the  OncoArray  project, for his vision and leadership, and who sadly passed away before seeing its fruition. We also thank the individuals who participated in these studies enabling this work. The  ELLIPSE/ PRACTICAL  (http//:practical. icr. ac. uk) prostate cancer consortium and his collaborating partners were supported by multiple funding mechanisms enabling this current work. ELLIPSE/PRACTICAL Genotyping of the OncoArray was funded by the  US National Institutes of Health (NIH)  ( U19 CA148537  for  ELucidating Loci Involved in Prostate Cancer SuscEptibility (ELLIPSE)  project and  X01HG007492  to the  Center for Inherited Disease Research (CIDR)  under contract number  HHSN268201200008I ).
Additional analytical support was provided by  NIH NCI   U01 CA188392  (F. R. S. ). Funding for the iCOGS infrastructure came from the  European Community 's  Seventh Framework Programme  under grant agreement  n°223175  ( HEALTH-F2-2009-223175 ) (COGS),  Cancer Research UK  ( C1287/A10118 ,  C1287/A 10710 ,  C12292/A11174 ,  C1281/A12014 ,  C5047/ A8384 ,  C5047/A15007 ,  C5047/A10692 , and  C8197/A16565 ), the  National Institutes of Health  ( CA128978 ) and  Post-Cancer GWAS initiative  ( 1U19 CA148537 ,  1U19 CA148065 , and  1U19 CA148112 ; the  GAME-ON initiative) , the  Department of Defense  ( W81XWH-10-1-0341 ), the  Canadian Institutes of Health Research (CIHR)  for the  CIHR Team in Familial Risks of Breast Cancer, Komen Foundation  for the Cure, the  Breast Cancer Research Foundation , and the  Ovarian Cancer Research Fund.
CA176785 an  NIH Specialized Program of Research Excellence (SPORE) in Breast Cancer  [ CA116201 ], and the  Breast Cancer Research Foundation  and a generous gift from the  David F. and Margaret T. Grohne Family Foundation. MCCS cohort recruitment was funded by  VicHealth  and  Cancer Council Victoria. The MCCS was further supported by Australian  NHMRC  grants  209057  and  396414 , and by infrastructure provided by  Cancer Council Victoria. Cases and their vital status were ascertained through the  Victorian Cancer Registry (VCR)  and the  Australian Institute of Health and Welfare (AIHW) , including the  National Death Index  and the Australian Cancer Database. The MEC was support by  NIH  grants  CA63464 ,  CA54281 ,  CA098758 ,  CA132839 , and  CA164973. The MISS study is supported by funding from  ERC -2011-294576 Advanced grant,  Swedish Cancer Society, Swedish Research Council, Local hospital funds, Berta Kamprad Foundation ,  Gunnar Nilsson.
The MMHS study was supported by  NIH  grants  CA97396 ,  CA128931 ,  CA116201 ,  CA140286 , and  CA177150. MSKCC is supported by grants from the  Breast Cancer Research Foundation and Robert and Kate Niehaus Clinical Cancer Genetics Initiative. The work of MTLGEBCS was supported by the  Quebec Breast Cancer Foundation , the  Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer " programgrant #  CRN-87521  and the  Ministry of Economic Development, Innovation  and Export Tradegrant #  PSR-SIIRI-701. MYBRCA is funded by research grants from the  Malaysian Ministry of Higher Education  ( UM. C/HlR/MOHE/ 06 ) and  Cancer Research Malaysia. MYMAMMO is supported by research grants from  Yayasan Sime Darby LPGA Tournament and Malaysian Ministry of Higher Education  ( RP046B-15HTM ).
The content of this manuscript does not necessarily reflect the views or policies of the  National Cancer Institute  or any of the collaborating centers in the  Breast Cancer Family Registry (BCFR) , nor does mention of trade names, commercial products, or organizations imply endorsement by the  USA Government  or the BCFR. The Carolina Breast Cancer Study was funded by  Komen Foundation , the  National Cancer Institute  ( P50 CA058223 ,  U54 CA156733 , and  U01 CA179715 ), and the  North Carolina University Cancer Research Fund. The NGOBCS was supported by  Grants-in-Aid for the Third Term Comprehensive Ten-Year Strategy for Cancer Control  from the  Ministry of Health, Labor and Welfare of Japan , and for  Scientific Research on Priority Areas, 17015049 and for Scientific Research on Innovative Areas ,  221S0001 , from the  Ministry of Education, Culture, Sports, Science, and Technology of Japan.
The NHS was supported by  NIH  grants  P01 CA87969 ,  UM1 CA186107 , and  U19 CA148065. The NHS2 was supported by  NIH  grants  UM1 CA176726  and  U19 CA148065. The OBCS was supported by research grants from the  Finnish Cancer Foundation , the  Academy of Finland  (grant number  250083 ,  122715  and  Center of Excellence  grant number  251314 ), the  Finnish Cancer Foundation , the  Sigrid Juselius Foundation , the  University of Oulu , the  University of Oulu Support Foundation , and the special Governmental EVO funds for Oulu University Hospital-based research activities. The ORIGO study was supported by the  Dutch Cancer Society  ( RUL 1997-1505 ) and the  Biobanking and Biomolecular Resources Research Infrastructure  ( BBMRI-NL CP16 ). The PBCS was funded by  Intramural Research Funds of the National Cancer Institute, Department of Health and Human Services, USA.
Genotyping for PLCO was supported by the  Intramural Research Program  of the  National Institutes of Health, NCI, Division of Cancer Epidemiology and Genetics. The PLCO is supported by the  Intramural Research Program of the Division of Cancer Epidemiology and Genetics  and supported by contracts from the  Division of Cancer Prevention, National Cancer Institute, National Institutes of Health. The POSH study is funded by  Cancer Research UK  (grants  C1275/ A11699 ,  C1275/C22524 ,  C1275/A19187 ,  C1275/A15956 , and  Breast Cancer Campaign   2010PR62 ,  2013PR044. PROCAS is funded from  NIHR  grant  PGfAR   0707-10031. The RBCS was funded by the  Dutch Cancer Society  ( DDHK 2004-3124 ,  DDHK 2009-4318 ). The SASBAC study was supported by funding from the  Agency for Science, Technology and Research of Singapore (A*STAR) , the  US National Institute of Health (NIH)  and the  Susan G.
Markham ,  Little Rock ,  AR 72205. The Arkansas Central Cancer Registry is fully funded by a grant from  National Program of Cancer Registries, Centers for Disease Control and Prevention (CDC). Data on SCCS cancer cases from Mississippi were collected by the  Mississippi Cancer Registry  which participates in the  HHSN268201600001C, HHSN268201600002C ,  HHSN268201600003C , and  HHSN26 8201600004C. The head and neck cancer genome-wide association analyses: The study was supported by  NIH/NCI :  P50 CA097190 , and  P30 CA047904 ,  Canadian Cancer Society Research Institute  (no. 020214 ) and  Cancer Care Ontario Research Chair  to R. H. The  Princess Margaret Hospital Head and Neck Cancer Translational Research Program  is funded by the  Wharton family, Joe's Team ,  Gordon Tozer ,  Bruce Galloway  and the  Elia family.
Geoffrey Liu  was supported by the  Posluns Family Fund  and the  Lusi Wong Family Fund at the Princess Margaret Foundation , and the  Alan B. Brown Chair in Molecular Genomics. This publication presents data from  Head and Neck 5000  ( H&N5000 ). H&N5000 was a component of independent research funded by the  UK National Institute for Health Research (NIHR)  under its  Programme Grants for Applied Research scheme  ( RP-PG-0707-10034 ). The views expressed in this publication are those of the author(s) and not necessarily those of the  NHS , the  NIHR  or the  Department of Health. Human papillomavirus (HPV)  in H&N5000 serology was supported by a  Cancer Research   UK Programme Grant , the  Integrative Cancer Epidemiology Programme  (grant number:  C18281/A19169 ). National Cancer Institute  ( R01-CA90731 );  National Institute of Environmental Health Sciences  ( P30ES10126 ).
The  Head and Neck Genome Project  ( GENCAPO)  was supported by the  Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)  (Grant numbers  04/ 12054-9  and  10/51168-0 ). The authors thank all the members of the  GENCAPO team. The HN5000 study was funded by the  National Institute for Health Research (NIHR)  under its  Programme Grants for Applied Research scheme  ( RP-PG-0707-10034 ), the views expressed in this publication are those of the author(s) and not necessarily those of the  NHS , the  NIHR  or the Department of Health. The Toronto study was funded by the  Canadian Cancer Society Research Institute  ( 020214 ) and the  National Cancer Institute  ( U19-CA148127 ) and the  Cancer Care Ontario Research Chair. The alcohol-related cancers and genetic susceptibility study in Europe (ARCAGE) was funded by the  European Commission 's  5th Framework Program  ( QLK1-2001-00182 ), the  Italian Association for Cancer Research ,  Compagnia di San Paolo/FIRMS ,  Region Piemonte , and  Padova University  ( CPDA057222 ).